Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ABSK112 for Lung Cancer
Recruiting1 awardPhase 1
Beverly Hills, California
This trial is testing ABSK112, a new drug, in patients with advanced lung cancer that has a specific genetic mutation. The goal is to see if the drug is safe and if it can help stop the cancer from growing.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service